Science 322(5901):587590 Yee SW, Gong L, Badagnani I, Giacomini KM, Klein TE, Altman RB (2010) SLC19A1 pharmacogenomics summary
7.2 Potential breakthroughs of organoids in dialysis treatment innovation In the field of dialysis treatment innovation, organoid technology is expected to achieve significant breakthroughs
Nutrient sensing, metabolism, and cell growth control
(JPAD) No injectable glutathione is not approved for cosmetic skin-lightening and the FDA has warned about safety concerns when non-pharmaceutical powders are used for compounding injectables
It enhances the function of immune cells, aids in detoxifying the liver, and regenerates other antioxidants
Injection site reactions to subcutaneous biologics: mechanisms and management. Journal of Clinical Immunology , 40(5), 745755